George K. Ng

This profile gathers the share dealings of George K. Ng in Processa Pharmaceuticals, Inc. The record holds 10 filings, for trades running from 10 October 2023 to 8 August 2026.

Purchases make up the whole of the open-market record (7 purchases, €115k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 1 option exercise. 2026 to date brings 5 purchases and no sales.

A typical purchase (the median) is worth €4,678. As a share of market capitalisation, the median purchase stands at 0.091%, based on 3 purchases. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -19.8%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 11 August 2026 with an option exercise in Processa Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 170 days ago, on 1 May 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.